Efficacy and safety of AYUSH-64 as standalone or adjunct to standard care in COVID-19: a structured summary of protocol for a systematic review

Registered with PROSPERO (CRD42021267844) dated 14.07.2021. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13643-022-01983-8.

Detalles Bibliográficos
Autores principales: Rai, Amit Kumar, Ahmad, Azeem, Mundada, Pallavi, Kumar V, Krishna, Yadav, Babita, Khanduri, Shruti, Chandrasekhararao, Bhogavalli, Srikanth, Narayanam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129058/
https://www.ncbi.nlm.nih.gov/pubmed/35610729
http://dx.doi.org/10.1186/s13643-022-01983-8
_version_ 1784712680886501376
author Rai, Amit Kumar
Ahmad, Azeem
Mundada, Pallavi
Kumar V, Krishna
Yadav, Babita
Khanduri, Shruti
Chandrasekhararao, Bhogavalli
Srikanth, Narayanam
author_facet Rai, Amit Kumar
Ahmad, Azeem
Mundada, Pallavi
Kumar V, Krishna
Yadav, Babita
Khanduri, Shruti
Chandrasekhararao, Bhogavalli
Srikanth, Narayanam
author_sort Rai, Amit Kumar
collection PubMed
description Registered with PROSPERO (CRD42021267844) dated 14.07.2021. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13643-022-01983-8.
format Online
Article
Text
id pubmed-9129058
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91290582022-05-25 Efficacy and safety of AYUSH-64 as standalone or adjunct to standard care in COVID-19: a structured summary of protocol for a systematic review Rai, Amit Kumar Ahmad, Azeem Mundada, Pallavi Kumar V, Krishna Yadav, Babita Khanduri, Shruti Chandrasekhararao, Bhogavalli Srikanth, Narayanam Syst Rev Letter Registered with PROSPERO (CRD42021267844) dated 14.07.2021. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13643-022-01983-8. BioMed Central 2022-05-24 /pmc/articles/PMC9129058/ /pubmed/35610729 http://dx.doi.org/10.1186/s13643-022-01983-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter
Rai, Amit Kumar
Ahmad, Azeem
Mundada, Pallavi
Kumar V, Krishna
Yadav, Babita
Khanduri, Shruti
Chandrasekhararao, Bhogavalli
Srikanth, Narayanam
Efficacy and safety of AYUSH-64 as standalone or adjunct to standard care in COVID-19: a structured summary of protocol for a systematic review
title Efficacy and safety of AYUSH-64 as standalone or adjunct to standard care in COVID-19: a structured summary of protocol for a systematic review
title_full Efficacy and safety of AYUSH-64 as standalone or adjunct to standard care in COVID-19: a structured summary of protocol for a systematic review
title_fullStr Efficacy and safety of AYUSH-64 as standalone or adjunct to standard care in COVID-19: a structured summary of protocol for a systematic review
title_full_unstemmed Efficacy and safety of AYUSH-64 as standalone or adjunct to standard care in COVID-19: a structured summary of protocol for a systematic review
title_short Efficacy and safety of AYUSH-64 as standalone or adjunct to standard care in COVID-19: a structured summary of protocol for a systematic review
title_sort efficacy and safety of ayush-64 as standalone or adjunct to standard care in covid-19: a structured summary of protocol for a systematic review
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129058/
https://www.ncbi.nlm.nih.gov/pubmed/35610729
http://dx.doi.org/10.1186/s13643-022-01983-8
work_keys_str_mv AT raiamitkumar efficacyandsafetyofayush64asstandaloneoradjuncttostandardcareincovid19astructuredsummaryofprotocolforasystematicreview
AT ahmadazeem efficacyandsafetyofayush64asstandaloneoradjuncttostandardcareincovid19astructuredsummaryofprotocolforasystematicreview
AT mundadapallavi efficacyandsafetyofayush64asstandaloneoradjuncttostandardcareincovid19astructuredsummaryofprotocolforasystematicreview
AT kumarvkrishna efficacyandsafetyofayush64asstandaloneoradjuncttostandardcareincovid19astructuredsummaryofprotocolforasystematicreview
AT yadavbabita efficacyandsafetyofayush64asstandaloneoradjuncttostandardcareincovid19astructuredsummaryofprotocolforasystematicreview
AT khandurishruti efficacyandsafetyofayush64asstandaloneoradjuncttostandardcareincovid19astructuredsummaryofprotocolforasystematicreview
AT chandrasekhararaobhogavalli efficacyandsafetyofayush64asstandaloneoradjuncttostandardcareincovid19astructuredsummaryofprotocolforasystematicreview
AT srikanthnarayanam efficacyandsafetyofayush64asstandaloneoradjuncttostandardcareincovid19astructuredsummaryofprotocolforasystematicreview

Ejemplares similares